BULL Pharmachem

FORSTAVIR LE tablets contain a combination of Efavirenz (600 mg), Lamivudine (300 mg), and Tenofovir Disoproxil Fumarate (300 mg). It is used for the treatment of HIV-1 infection by inhibiting viral replication. This combination therapy helps reduce viral load, improve immune function, and manage HIV progression in adults.

Emtricitabine and Tenofovir Disoproxil Fumarate Tablets are used to treat HIV-1 infection. Both drugs inhibit viral replication, reducing the virus's ability to multiply. This combination therapy lowers viral load, boosts immune function, and helps prevent HIV progression. It’s also used in pre-exposure prophylaxis (PrEP) to reduce HIV risk.

FORSTAVIR is a combination tablet containing Tenofovir Disoproxil Fumarate, Lamivudine, and Efavirenz, used to treat HIV-1 infection. It works by inhibiting viral replication, reducing viral load, and improving immune function. FORSTAVIR helps manage HIV progression, enhances immune response, and provides effective long-term treatment for HIV-positive individuals.

Tenofovir Disoproxil Fumarate 300mg tablets are an antiviral medication used to treat HIV-1 infection and chronic hepatitis B. It works by inhibiting viral replication, reducing the viral load, and improving immune function. This medication helps manage HIV progression and improve the quality of life for affected individuals.

Tenofovir Alafenamide 300mg Tablets are used to treat HIV-1 infection and chronic hepatitis B. They work by inhibiting viral replication, reducing viral load, and improving immune function. This medication is more effective and has a better safety profile than Tenofovir Disoproxil Fumarate, offering enhanced treatment for long-term management.

Tafsure (Tenofovir Alafenamide 25 mg) is an antiviral medication used to treat HIV and chronic hepatitis B. It works by inhibiting the replication of the virus, reducing viral load, and improving immune function. Tafsure is typically prescribed as part of combination therapy to effectively manage these viral infections.

Tenofovir Alafenamide tablets are used to treat HIV and chronic hepatitis B. As a nucleoside reverse transcriptase inhibitor, it works by blocking viral replication, reducing viral load, and improving immune function. It is often prescribed as part of combination therapy to manage and control these viral infections effectively.

Tenofovir Alafenamide tablets are used to treat HIV and chronic hepatitis B. As a nucleoside reverse transcriptase inhibitor, it works by blocking viral replication, reducing viral load, and improving immune function. It is often prescribed as part of combination therapy to manage and control these viral infections effectively.

Tafnat is a combination tablet containing Tenofovir Alafenamide and Emtricitabine, used to treat HIV infection. It works by inhibiting the replication of the virus, reducing viral load, and improving immune function. Tafnat is typically prescribed as part of a combination antiretroviral therapy to manage HIV effectively.

Tenfoplus tablets contain Tenofovir Disoproxil Fumarate and Emtricitabine, used to treat HIV and chronic hepatitis B. These antiviral medications work by inhibiting the replication of the virus, reducing viral load, and improving immune function. Tenfoplus is commonly prescribed as part of combination therapy to effectively manage and control these viral infections.

Darunavir + Ritonavir tablets are antiretroviral medications used to treat HIV-1 infection. Darunavir inhibits the HIV protease enzyme, while Ritonavir boosts its effectiveness by increasing its blood levels. This combination helps lower viral load and boost immune function, improving patient outcomes.

Darunavir + Ritonavir tablets are antiretroviral medications used to treat HIV-1 infection. Darunavir inhibits the HIV protease enzyme, while Ritonavir boosts its effectiveness by increasing its blood levels. This combination helps lower viral load and boost immune function, improving patient outcomes.

Darunavir tablets are antiretroviral drugs used to treat HIV-1 infection, typically in combination with other medications. As a protease inhibitor, darunavir blocks an essential enzyme needed for HIV replication, helping to reduce viral load, slow disease progression, and improve immune system function.

Lamivudine and zidovudine tablets are antiretroviral agents used in combination to treat HIV-1 infection. They inhibit reverse transcriptase, an essential viral enzyme, reducing HIV replication. This combination helps lower viral load, improve immune function, and delay progression to AIDS when used with other therapies.

Lamivudine and zidovudine tablets are antiretroviral agents used in combination to treat HIV-1 infection. They inhibit reverse transcriptase, an essential viral enzyme, reducing HIV replication. This combination helps lower viral load, improve immune function, and delay progression to AIDS when used with other therapies.

Lamivudine and zidovudine tablets are antiretroviral agents used in combination to treat HIV-1 infection. They inhibit reverse transcriptase, an essential viral enzyme, reducing HIV replication. This combination helps lower viral load, improve immune function, and delay progression to AIDS when used with other therapies.

Darunavir Ethanolate is a potent antiretroviral protease inhibitor used in the treatment of HIV-1 infection. It blocks the HIV protease enzyme, preventing viral replication and maturation. Administered with other antiretrovirals, it helps lower viral load, boost immune response, and improve long-term treatment outcomes.

Darunavir is a powerful antiretroviral protease inhibitor used in the treatment of HIV-1 infection. It blocks the HIV protease enzyme, preventing viral replication and the formation of mature virus. Used with other antiretrovirals, it effectively reduces viral load and enhances immune function.

Abacavir 300 mg + Dolutegravir 50 mg + Lamivudine 300 mg is a powerful once-daily antiretroviral combination used to treat HIV-1 infection. It suppresses viral replication, enhances immune response, improves patient outcomes, and helps prevent transmission, supporting long-term viral suppression and better quality of life.

Lopinavir & Ritonavir tablets are potent antiretroviral medications used in combination therapy to manage HIV-1 infection. Ritonavir boosts lopinavir’s effectiveness by inhibiting its metabolism, enhancing viral suppression. This fixed-dose combination helps improve immune function and reduce the risk of HIV-related complications.

Dolutegravir Tablets are advanced antiretroviral medications used to treat HIV-1 infection. As an integrase strand transfer inhibitor (INSTI), Dolutegravir blocks viral replication by preventing integration into the host genome. It offers rapid viral suppression, improved immune function, and a high barrier to resistance.

Viraday is a combination tablet containing Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz, used to treat HIV-1 infection. It works by inhibiting viral replication, reducing viral load, and improving immune function. Viraday helps manage HIV progression, enhance immune health, and provides effective treatment for individuals living with HIV.

TRUSTIVA is a combination tablet containing Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate, used to treat HIV-1 infection. It works by inhibiting viral replication, reducing viral load, and improving immune function. TRUSTIVA helps manage HIV progression, enhances immune response, and improves the quality of life for HIV-infected individuals.